$YBCN
Yong Bai Chao New Retail Corp

2021 Q4 Form 10-Q Financial Statement

#000147793221008778 Filed on November 24, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q4
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $8.990K $7.160K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $8.990K $7.156K
YoY Change -69.4%
Operating Profit -$7.156K
YoY Change -69.4%
Interest Expense -$6.250K -$6.250K
YoY Change
% of Operating Profit
Other Income/Expense, Net -$6.250K
YoY Change -60.89%
Pretax Income $39.13K -$13.41K
YoY Change -65.94%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings $39.13K -$13.41K
YoY Change -65.94%
Net Earnings / Revenue
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $288.50 $0.00
COMMON SHARES
Basic Shares Outstanding 135.6M shares 135.6M shares
Diluted Shares Outstanding 141.3M shares

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $0.00
YoY Change
Cash & Equivalents $0.00 $0.00 $0.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $0.00 $0.00 $0.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $0.00 $0.00 $0.00
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $0.00 $0.00 $0.00
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.430K $0.00 $0.00
YoY Change
Accrued Expenses $252.3K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $250.0K $300.0K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $518.5K $607.6K $580.5K
YoY Change -10.68%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $518.5K $607.6K $580.5K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $518.5K $607.6K $580.5K
YoY Change -10.68%
SHAREHOLDERS EQUITY
Retained Earnings -$3.517M -$3.557M -$2.767M
YoY Change 27.14%
Common Stock $141.9K $141.9K $111.9K
YoY Change 26.8%
Preferred Stock
YoY Change
Treasury Stock (at cost) $375.00 $0.00
YoY Change
Treasury Stock Shares 375.0K shares
Shareholders Equity -$518.5K -$607.6K -$580.5K
YoY Change
Total Liabilities & Shareholders Equity $0.00 $0.00 $0.00
YoY Change

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q4
OPERATING ACTIVITIES
Net Income $39.13K -$13.41K
YoY Change -65.94%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $0.00 $9.850K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change
NET CHANGE
Cash From Operating Activities 0.000 9.850K
Cash From Investing Activities
Cash From Financing Activities 0.000
Net Change In Cash 0.000 9.850K
YoY Change
FREE CASH FLOW
Cash From Operating Activities $0.00 $9.850K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
135569068 shares
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2431 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
53118 USD
CY2021Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
300459 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
0 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
0 USD
CY2021Q3 us-gaap Assets
Assets
0 USD
CY2020Q4 us-gaap Assets
Assets
0 USD
CY2020Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
227339 USD
CY2021Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
4725 USD
CY2020Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
0 USD
CY2021Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
50000 USD
CY2020Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
50000 USD
CY2021Q3 evcc Convertible Debentures Related Parties
ConvertibleDebenturesRelatedParties
250000 USD
CY2020Q4 evcc Convertible Debentures Related Parties
ConvertibleDebenturesRelatedParties
250000 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
607615 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
580457 USD
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
180000000 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
135569068 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
105569068 shares
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
141945 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
111945 USD
CY2021Q3 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
2282 USD
CY2020Q4 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
2282 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2804763 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2071913 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3556605 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2766597 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-607615 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-580457 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 USD
CY2021Q3 us-gaap Revenues
Revenues
0 USD
CY2020Q3 us-gaap Revenues
Revenues
0 USD
us-gaap Revenues
Revenues
0 USD
us-gaap Revenues
Revenues
0 USD
CY2021Q3 evcc Consulting Fees
ConsultingFees
0 USD
CY2020Q3 evcc Consulting Fees
ConsultingFees
0 USD
evcc Consulting Fees
ConsultingFees
753000 USD
evcc Consulting Fees
ConsultingFees
0 USD
CY2021Q3 us-gaap Professional Fees
ProfessionalFees
7156 USD
CY2020Q3 us-gaap Professional Fees
ProfessionalFees
21175 USD
us-gaap Professional Fees
ProfessionalFees
17006 USD
us-gaap Professional Fees
ProfessionalFees
21175 USD
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
0 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2207 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
0 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2207 USD
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
7156 USD
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
23382 USD
us-gaap Operating Expenses
OperatingExpenses
770006 USD
us-gaap Operating Expenses
OperatingExpenses
23382 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7156 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-23382 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-770006 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-23382 USD
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2020Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2021Q3 us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-6250 USD
CY2020Q3 us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-15982 USD
us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-20002 USD
us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-47946 USD
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-6250 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-15982 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-20002 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-47946 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-13406 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-39364 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-790008 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-71328 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-13406 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-39364 USD
us-gaap Net Income Loss
NetIncomeLoss
-790008 USD
us-gaap Net Income Loss
NetIncomeLoss
-71328 USD
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
135569068 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
105569068 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
125678958 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
105569068 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
141283353 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
105569068 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
125678958 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
105569068 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-580457 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-13502 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-593959 USD
CY2021Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
753000 USD
CY2021Q2 evcc Conversion Of Related Party Payable To Equity
ConversionOfRelatedPartyPayableToEquity
9850 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-763100 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-594209 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-13406 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-607615 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-1341282 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-15982 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-1357264 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-15982 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-1373246 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-39364 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-1412610 USD
us-gaap Net Income Loss
NetIncomeLoss
-790008 USD
us-gaap Net Income Loss
NetIncomeLoss
-71328 USD
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
753000 USD
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
0 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-50687 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
71328 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
73120 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
0 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
14575 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
0 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
0 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
0 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
0 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
0 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
evcc Conversion Of Related Party Payable To Equity
ConversionOfRelatedPartyPayableToEquity
9850 USD
evcc Conversion Of Related Party Payable To Equity
ConversionOfRelatedPartyPayableToEquity
0 USD
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Significant estimates during the three and nine months ended September 30, 2021 and 2020 include valuation of deferred tax assets and the associated valuation allowances, and valuation of stock-based compensation. </p>
CY2021Q3 evcc Working Capital Deficit
WorkingCapitalDeficit
-607615 USD
us-gaap Profit Loss
ProfitLoss
-790008 USD
evcc Common Stock Shares Issued For Services
CommonStockSharesIssuedForServices
30000000 shares
evcc Common Stock Value Issued For Services
CommonStockValueIssuedForServices
753000 USD
evcc Stock Based Consulting Fees
StockBasedConsultingFees
753000 USD
CY2009Q3 evcc Investor Relations Agreement Description
InvestorRelationsAgreementDescription
Pursuant to the agreement, the Company agreed to pay a fee of $ 1,000 per month for a period of six months beginning on August 1, 2009 and ending January 1, 2010. The Company must also issue 75,000 shares within 7 days of signing the agreement. Any payments over 45 days will be subject to a penalty fee of 10% per week.
CY2009Q3 us-gaap Other Commitment
OtherCommitment
1000 USD
CY2009Q3 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
75000 shares
CY2009Q3 evcc Penalty Fees
PenaltyFees
0.10 pure
CY2010Q1 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
75000 shares
CY2009Q4 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
2282 USD
CY2010Q1 evcc Additional Shares Issued
AdditionalSharesIssued
75000 shares
CY2021Q3 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
2282 USD

Files In Submission

Name View Source Status
0001477932-21-008778-index-headers.html Edgar Link pending
0001477932-21-008778-index.html Edgar Link pending
0001477932-21-008778.txt Edgar Link pending
0001477932-21-008778-xbrl.zip Edgar Link pending
evcc-20210930.xsd Edgar Link pending
evcc-20210930_cal.xml Edgar Link unprocessable
evcc-20210930_def.xml Edgar Link unprocessable
evcc-20210930_lab.xml Edgar Link unprocessable
evcc-20210930_pre.xml Edgar Link unprocessable
evcc_10q.htm Edgar Link pending
evcc_10q_htm.xml Edgar Link completed
evcc_ex311.htm Edgar Link pending
evcc_ex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending